FDA bans imports from Sun Pharma plant in India crackdown #pharma #packaging #solutions

Posted On Oct 29 2016 by

#sun pharma # FDA bans imports from Sun Pharma plant in India crackdown By Zeba Siddiqui and Sumeet Chatterjee | MUMBAI MUMBAI (Reuters) – The U.S. Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd’s plant at Karkhadi in the western state of Gujarat, in the latest quality blow for India’s drug sector. The FDA has imposed a rash of regulatory sanctions on Indian generic makers in the last year, triggering concerns about the quality of the medicines supplied by the $14 billion industry to countries including the United States, the biggest market. …


India s Sun Pharma Gets U #7tm #pharma

Posted On Oct 29 2016 by

#sun pharma # India’s Sun Pharma Gets U.S. Subpoena Over Generic Drugs Pricing The U.S. Department of Justice (DoJ) has subpoenaed India s largest drugmaker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday. The DoJ s antitrust division has also asked Sun Pharma s U.S. unit for documents related to employee and corporate records and communications with competitors. The subpoena comes amid a wider probe by U.S. regulators into steep increases in the prices of generic medicines in recent years. For more …


India pharma #thompson #pharma

Posted On Oct 29 2016 by

#india pharma # AstraZeneca Pharma India Limited (AZPIL) has interests in seven crucial areas of healthcare: • Brilinta® (Ticagrelor Tablets 90mg) • Betaloc® (Metoprolol Tartrate Tablets IP 25mg, 50mg 100mg) • Seloken XL® (Metoprolol Succinate Extended Release Tablets USP 25mg, 50mg 100mg) • Imdur® (Prolonged Release Isosorbide-5-Mononitrate Tablets BP 30mg 60mg) • Crestor® (Rosuvastatin Tablets IP 5mg, 10mg, 20mg 40mg) • Seloram™ (Metoprolol Succinate Extended Release Ramipril Tablets 25/2.5mg, 25/5mg 50/5mg) • Vigocil® (Voglibose Orally Disintegrating Tablets 0.2mg 0.3mg) • Vigocil M® (Voglibose and Metformin Hydrochloride Tablets 0.2/500mg 0.3/500mg) • Nitract SR™ (Nitroglycerin Sustained Release Capsules 2.5mg 6.5mg) • Valfect™ …


PHARMACEUTICALS – Make In India #euro #pharma

Posted On Oct 29 2016 by

#india pharma # SUMMARY Third largest pharmaceuticals market by 2020 in terms of incremental growth. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. India’s filing of Drug Master Files’s (DMF’s) with USFDA as of Dec 2013 is 3411, the highest filed by any country in the world. …


India Pharma 2017 #crm #pharma

Posted On Oct 29 2016 by

#india pharma # Exhibition Overview India Pharma 2017 will cover all the sectors of the pharmaceutical industry starting from finished formulations, APIs, Bio-pharmaveuticals, Fine Chemicals and intermediates, Natural extracts, Excipients and many more. Display of Latest Pharmaceutical Machinery, Plants, Laboratory Equipment, Analytical Instrument and Cleanroom Equipments. Direct Access to Highly targeted Senior Pharma Executives, Buyers, Procurement Managers, Contract Manufacturers. Highlights – India Pharma 2016 Why Visit? – India Pharma 2017 The previous edition of India Pharma 2016 received tremendous response from the participants; with more than 150 exhibitors, including 29 overseas exhibitors from 11 countries, and country pavilions of Japan …


Pharmaceutical Research and Manufacturers, Pharma Products Suppliers In India #pharmaceutical #industry #profile

Posted On Oct 28 2016 by

#pharma manufacturer # Belco Pharma i s a WHO GMP certified company and is manufacturing Pharmaceutical formulations since 1975. The company is into manufacturing and development of pharmaceutical formulations under almost all dosage forms and categories of drugs, manufacturing more than 300 products. The company is among the leading generics and branded generics companies in India have a strong export base clientele and market capitalization. The company mainly caters to international markets and is working in about 25 counties and has strategic tie ups with various multinational and leading national companies for manufacturing their products for their own markets around …


Pharma CRM – DynPro India #generic #drug #company

Posted On Oct 28 2016 by

#pharma crm # Pharmaceutical companies’ focuses on enrichment the lifetime for customers, a good customer relationship management plays a main role in the company success. DynProCRM Pharma Edition 2.0 is a specialized industry vertically built by DynPro to support the needs of both offices based and travelling pharmaceutical product sales representatives as they promote and support the sales cycle. DynPro s CRM software solution covers many of the customer-related processes that are part of daily business for the pharma industries. Our Cloud CRM Pharma software solutions includes best-in-class industry-specific functionality and embedded pharmaceutical best practices. It s no accident that …


Top Pharmaceutical Companies in India, List of Best Pharma Company, Big #map #pharma

Posted On Oct 28 2016 by

#pharmaceutical manufacturers # Pharmaceutical Companies in India Increasing investments in the sector The Indian pharmaceuticals market increased at a CAGR of 17.46 per cent in 2015 from US$ 6 billion in 2005 and is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020. By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size. India s cost of production is significantly lower than that of the US and almost half of that of Europe. It gives a competitive edge to …


PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA #pharmaceutical #publications

Posted On Oct 27 2016 by

#pharma india # Mr. Madan Mohan Reddy, Director, Aurobindo Pharma Limited has taken charge as Chairman, Pharmexcil during 65th COA Meeting held at Hyderabad on 22 July 2016 29-30 August 2016, 2 Day National Conference on Packaging of Pharmaceutical Products and Its Safety Aspects organised by Indian Institute of Packaging, Mumbai (supported by Pharmexcil) 29-30 August 2016, 2 Day National Conference on Packaging of Pharmaceutical Products and Its Safety Aspects organised by Indian Institute of Packaging, Mumbai (supported by Pharmexcil) 29 August 2016, Boosting exports to Europe & US – Interactive Meet with Shri Sudhanshu Pandey, IAS, Joint Secretary, Department …


India – s Pharmaceutical industry is on a good growth path, but will have to

Posted On Oct 26 2016 by

#future of pharmaceutical industry # India’s Pharmaceutical industry is on a good growth path, but will have to watch out for the regulatory interventions The Indian pharma industry is on a good growth path and is likely to be in the top 10 global markets in value term by 2020. according to the PwC – CII report titled “India Pharma Inc: Gearing up for the next level of growth”. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market, the report highlighted. The …